Duration of immunotherapy in patients with advanced lung adenocarcinoma with negative driver genes: case report and literature review

Here, we report two cases of advanced non‐small cell lung cancer (NSCLC) in patients with negative driver genes who received ICI treatment for less than two years but continued to benefit from their administration after drug withdrawal. The first patient was diagnosed with left lung adenocarcinoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Qinge, Wang, Haiyong, Han, Xiao, Guo, Jun, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529576/
https://www.ncbi.nlm.nih.gov/pubmed/32833320
http://dx.doi.org/10.1111/1759-7714.13600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529576/
https://www.ncbi.nlm.nih.gov/pubmed/32833320
http://dx.doi.org/10.1111/1759-7714.13600

Ejemplares similares